Results 171 to 180 of about 21,293 (203)

Tenofovir disoproxil fumarate

Reactions Weekly, 2021
  +4 more sources

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Lancet, The, 2021
Shahin Lockman, Lynda Stranix-Chibanda, Lee Fairlie   +2 more
exaly  

Tenofovir disoproxil fumarate

Reactions Weekly, 2011
  +4 more sources

Tenofovir-disoproxil-fumarate

Reactions Weekly, 2023
openaire   +1 more source

Tenofovir disoproxil fumarate

Reactions Weekly, 2014
  +4 more sources

Tenofovir disoproxil fumarate

Reactions Weekly, 2010
  +5 more sources

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate

Clinical Gastroenterology and Hepatology, 2022
Kwan Soo Byun, Jonggi Choi, Han Chu Lee
exaly  

Tenofovir-disoproxil-fumarate

Reactions Weekly, 2019
openaire   +2 more sources

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B

Liver International, 2022
Jihye Lim, Won-Mook Choi, Ju Hyun Shim
exaly  

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Jean-Michel Molina, Peter L Anderson   +2 more
exaly